SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-20-000135
Filing Date
2020-09-08
Accepted
2020-09-08 16:05:46
Documents
17
Period of Report
2020-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20200903.htm   iXBRL 8-K 51730
2 EX-10.1 exhibit101separationag.htm EX-10.1 90794
3 EX-99.1 exhibit991pressrelease.htm EX-99.1 12877
9 image1.jpg GRAPHIC 9719
  Complete submission text file 0000849146-20-000135.txt   335333

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20200903.xsd EX-101.SCH 2445
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20200903_cal.xml EX-101.CAL 728
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20200903_def.xml EX-101.DEF 1665
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20200903_lab.xml EX-101.LAB 25298
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20200903_pre.xml EX-101.PRE 13208
10 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20200903_htm.xml XML 11168
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 201164248
SIC: 2834 Pharmaceutical Preparations